363 related articles for article (PubMed ID: 20813865)
21. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
22. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
23. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
[TBL] [Abstract][Full Text] [Related]
24. A SPAK isoform switch modulates renal salt transport and blood pressure.
McCormick JA; Mutig K; Nelson JH; Saritas T; Hoorn EJ; Yang CL; Rogers S; Curry J; Delpire E; Bachmann S; Ellison DH
Cell Metab; 2011 Sep; 14(3):352-64. PubMed ID: 21907141
[TBL] [Abstract][Full Text] [Related]
25. Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.
Davies M; Fraser SA; Galic S; Choy SW; Katerelos M; Gleich K; Kemp BE; Mount PF; Power DA
Am J Physiol Renal Physiol; 2014 Jul; 307(1):F96-F106. PubMed ID: 24808538
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.
Richardson C; Sakamoto K; de los Heros P; Deak M; Campbell DG; Prescott AR; Alessi DR
J Cell Sci; 2011 Mar; 124(Pt 5):789-800. PubMed ID: 21321328
[TBL] [Abstract][Full Text] [Related]
27. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation regulates NCC stability and transporter activity in vivo.
Yang SS; Fang YW; Tseng MH; Chu PY; Yu IS; Wu HC; Lin SW; Chau T; Uchida S; Sasaki S; Lin YF; Sytwu HK; Lin SH
J Am Soc Nephrol; 2013 Oct; 24(10):1587-97. PubMed ID: 23833262
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of WNK3 Kinase Signaling Reduces Brain Damage and Accelerates Neurological Recovery After Stroke.
Begum G; Yuan H; Kahle KT; Li L; Wang S; Shi Y; Shmukler BE; Yang SS; Lin SH; Alper SL; Sun D
Stroke; 2015 Jul; 46(7):1956-1965. PubMed ID: 26069258
[TBL] [Abstract][Full Text] [Related]
30. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.
de Los Heros P; Alessi DR; Gourlay R; Campbell DG; Deak M; Macartney TJ; Kahle KT; Zhang J
Biochem J; 2014 Mar; 458(3):559-73. PubMed ID: 24393035
[TBL] [Abstract][Full Text] [Related]
31. WNK signalling pathways in blood pressure regulation.
Murthy M; Kurz T; O'Shaughnessy KM
Cell Mol Life Sci; 2017 Apr; 74(7):1261-1280. PubMed ID: 27815594
[TBL] [Abstract][Full Text] [Related]
32. On the substrate recognition and negative regulation of SPAK, a kinase modulating Na+-K+-2Cl- cotransport activity.
Gagnon KB; Delpire E
Am J Physiol Cell Physiol; 2010 Sep; 299(3):C614-20. PubMed ID: 20463172
[TBL] [Abstract][Full Text] [Related]
33. Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.
Gao JL; Peng K; Shen MW; Hou YH; Qian XB; Meng XW; Ji FH; Wang LN; Yang JP
J Pain; 2019 Dec; 20(12):1416-1428. PubMed ID: 31085334
[TBL] [Abstract][Full Text] [Related]
34. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
35. STE20/SPS1-related proline/alanine-rich kinase is involved in plasticity of GABA signaling function in a mouse model of acquired epilepsy.
Yang L; Cai X; Zhou J; Chen S; Chen Y; Chen Z; Wang Q; Fang Z; Zhou L
PLoS One; 2013; 8(9):e74614. PubMed ID: 24058604
[TBL] [Abstract][Full Text] [Related]
36. NF-κB Signaling-Mediated Activation of WNK-SPAK-NKCC1 Cascade in Worsened Stroke Outcomes of Ang II-Hypertensive Mice.
Bhuiyan MIH; Young CB; Jahan I; Hasan MN; Fischer S; Meor Azlan NF; Liu M; Chattopadhyay A; Huang H; Kahle KT; Zhang J; Poloyac SM; Molyneaux BJ; Straub AC; Deng X; Gomez D; Sun D
Stroke; 2022 May; 53(5):1720-1734. PubMed ID: 35272484
[TBL] [Abstract][Full Text] [Related]
37. Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2.
Park HJ; Curry JN; McCormick JA
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1687-96. PubMed ID: 24133122
[TBL] [Abstract][Full Text] [Related]
38. WNK3-SPAK interaction is required for the modulation of NCC and other members of the SLC12 family.
Pacheco-Alvarez D; Vázquez N; Castañeda-Bueno M; de-Los-Heros P; Cortes-González C; Moreno E; Meade P; Bobadilla NA; Gamba G
Cell Physiol Biochem; 2012; 29(1-2):291-302. PubMed ID: 22415098
[TBL] [Abstract][Full Text] [Related]
39. OSR1 and SPAK cooperatively modulate Sertoli cell support of mouse spermatogenesis.
Liu YL; Yang SS; Chen SJ; Lin YC; Chu CC; Huang HH; Chang FW; Yu MH; Lin SH; Wu GJ; Sytwu HK
Sci Rep; 2016 Nov; 6():37205. PubMed ID: 27853306
[TBL] [Abstract][Full Text] [Related]
40. Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke.
Josiah SS; Meor Azlan NF; Zhang J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
